TCam-2 seminoma cell line exhibits characteristic foetal germ cell responses to TGF-beta ligands and retinoic acid

Int J Androl. 2011 Aug;34(4 Pt 2):e204-17.
Young JC, Jaiprakash A, Mithraprabhu S, Itman C, Kitazawa R, Looijenga LH, Loveland KL.
Int J Androl. 2011 Aug;34(4 Pt 2):e204-17.
E' stata dimostrata la capacità dell'acido retinoico, del TGF-beta (fattore di crescita trasformante) e della proteina morfogenetica (BMP4) nel migliorare la sopravvivenza del feto e la proliferazione delle cellule germinali / auto-rinnovantisi.
RA-TFG-beta-BMP4/seminoma, carcinoma in situ.
Germ cell testicular cancer is understood to arise during embryogenesis, based on the persistence of embryonic germ cell markers in carcinoma in situ and seminoma. In this study, we examine the potential of the seminoma-derived TCam-2 cell line to be used as representative in functional analyses of seminoma. We demonstrate expression of several early germ cell markers, including BLIMP1, OCT3/4, AP2γ, NANOG and KIT. Many TGF-beta superfamily receptors and downstream transcription factors are also present in these cells including the normally foetal ACTRIIA receptor, indicating potential responsiveness to TGF-beta superfamily ligands. Treatment with BMP4 or RA induces a significant increase in ACTRIA, ACTRIIA and ACTRIIB transcripts, whereas activin A decreases ACTRIB. BMP4 and RA each support TCam-2 survival and/or proliferation. In addition, despite increased KIT mRNA levels induced by BMP4, RA and activin A, activin A does not improve survival or proliferation. The capacity for BMP4 and retinoic acid to enhance foetal germ cell survival and proliferation/self-renewal has been demonstrated in mice, but not previously tested in humans. This study is the first to demonstrate a functional response in seminoma cells, using a well-characterized cell line, consistent with their foetal germ cell-like identity.